Best Clinical Labs IT Companies in South Korea
The 34 best Clinical Labs IT companies in South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Lunit.
Ranked: Best Clinical Labs IT companies in South Korea
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Lunit Developer of artificial intelligence solutions for cancer detection and treatment | $135M | 58 mo ago | Public | — | 2013 | WordPressMySQLPHP+25 | 387 patents AI-driven analysis and annotation of pathology slide images | — |
| 2 | heuron Provider of AI-based clinical diagnosis software for doctors | $13M | 70 mo ago | Series B | Donghoon Shin CEO | 2019 | — | 97 patents AI-driven MRI brain imaging analysis: neuromelanin, nigrosome, choroid plexus, vascular metrics | — |
| 3 | Vuno Developer of AI based medical image analysis software for healthcare providers | $12M | 10 mo ago | Public | Hyun-Jun Kim Co-Founder & CSO | 2014 | Apple iCloud MailMicrosoft 365PHP+20 | 322 patents AI-driven ECG and medical imaging analysis, visualization, and bio-signal processing tools | — |
| 4 | OncoSoft Developer of AI-based software for radiation therapy contouring and planning | $11M | 25 mo ago | Series B | Jinsung Kim CEO | 2019 | — | 22 patents Patents concentrated in health & consumer products | — |
| 5 | monitor AI-based medical image analysis tool for radiology | $5M | 24 mo ago | Series B | Kyong Joon Lee Chief Executive Officer | 2018 | — | 27 patents AI-powered lung nodule risk assessment and medical image analysis software | — |
| 6 | SYM Healthcare AI-based disease detection tool for providers | $233K | 51 mo ago | Seed | Ahn Jung-hoon CEO | 2018 | — | 8 patents AI-powered 3D motion and posture analysis for musculoskeletal injury diagnosis and rehabilitation | — |
| 7 | VIENCE Provider of a bio-medical imaging AI analysis platform | — | 33 mo ago | Seed | Jeong Won-gi CEO | 2021 | — | 2 patents Patents concentrated in computing, sensing & instrumentation | — |
| 8 | DeepBio Developer of image analysis platform for prostate cancer diagnosis | — | 112 mo ago | Seed | Sun Woo Kim Ceo / Founder | 2015 | — | — | — |
Top 8 Clinical Labs IT companies in South Korea
#1
Public · Seoul, Seoul · founded 2014 · 163 employees$12Mraised▾
Developer of AI based medical image analysis software for healthcare providers. The company's solutions analyzes a wide range of medical data that can be combined with artificial intelligence. The company's products include Med-BoneAge, Med-DeepBrain, Med-Chest X-ray, Med-Fundus AI, Med-LungCT AI and more.
- Dec 2025Post IPO$6.8M
- Nov 2018Series B$12M
- 2015Seed—
#2
Series B · Chuncheon si, Gangwon Province · founded 2019 · 14 employees$11.2Mraised▾
Developer of AI-based software for radiation therapy contouring and planning. The software provides automated organ contour samples without user intervention, interfacing with commercially available hardware and software. It generates consistent contours resembling peer-reviewed quality with expert-level accuracy. The software supports organs at risk and clinical target volumes for CT, MR, and cone-beam CT. The solution offers a data-centric workflow and efficient data processing capabilities.
- Sep 2024Series B$8.2M
- Aug 2022Series A$2.7M
#3
Public · Seoul, Seoul · founded 2013 · 279 employees$135Mraised▾
Developer of artificial intelligence solutions for cancer detection and treatment. The company’s technology supports early-stage cancer detection, enabling timely management and increased survival chances. It also provides artificial intelligence biomarkers for immunotherapy, predicting treatment response to increase efficacy. The company focuses on advancing precision oncology products.
- Nov 2021Series C$61M
- Jul 2021Series C$26M
- Jan 2020Series C$26M
- Jul 2018Series B$15M
#4
Series B · Seoul, Seoul · founded 2018 · 18 employees$5.3Mraised▾
Developer of medical imaging technology designed for cancer detection. The company develops medical image diagnostic assistant software that uses a neural network algorithm that automatically detects pulmonary nodules, measures the long and short diameters of a nodule, as well as registers it to the system database, enabling radiologists to access suitable tools to read chest CT images more efficiently.
- Oct 2024Series B$5.3M
- 2021Series A—
- 2020Seed—
#5
Series B · Incheon, Incheon · founded 2019 · 56 employees$13.4Mraised▾
iheuron provides AI-based clinical diagnosis software for doctors. They are developing a diagnostic assistant platform for brain nerve disorders like Dementia, Stroke, and Parkinson's disease. The pipeline products are mPDi, cASPETia, mDEMENTIA.
- Dec 2020Series B$11.2M
- Jul 2019Series A$2.2M
#6
Seed · Seoul, Seoul · founded 2018$232.6Kraised▾
AI-based disease detection tool for providers. The company has developed an image-based disease diagnosis tool. It has features for musculoskeletal disease diagnosis, incorrect movement analysis, movement pattern detection, and more.
- Jun 2022Seed$232.6K
#7
Seed · Seoul, Seoul · founded 2021—raised▾
Provider of a bio-medical imaging AI analysis platform. The company offers Vience Canvas an AI visual analysis platform, Cellview programming-based cell analysis platform, and Pathoview a pathology diagnosis solution.
- Jan 2024Seed—
#8
Seed · Seoul, Seoul · founded 2015 · 29 employees—raised▾
Developer of image analysis platform for prostate cancer diagnosis. The company is using Artificial intelligence for developing a platform that can diagnose and classify prostate cancer from biopsy images.
- 2017Seed—
Funding & investor landscape
Notable founders
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.